Treatment in germ cell tumours: state of the art
- 1 April 1997
- journal article
- review article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 23 (2) , 110-117
- https://doi.org/10.1016/s0748-7983(97)80002-9
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Accelerated chemotherapy for poor prognosis germ cell tumoursEuropean Journal Of Cancer, 1994
- A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumoursEuropean Journal Of Cancer, 1993
- Phase II Trial of High-Dose Carboplatin and Etoposide With Autologous Bone Marrow Transplantation in First-Line Therapy for Patients With Poor-Risk Germ Cell TumorsJNCI Journal of the National Cancer Institute, 1993
- Post‐orchiectomy management in stage I testicular seminoma: Elective irradiation or surveillance?Australasian Radiology, 1993
- The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumorsCancer, 1990
- HISTOPATHOLOGY IN THE PREDICTION OF RELAPSE OF PATIENTS WITH STAGE I TESTICULAR TERATOMA TREATED BY ORCHIDECTOMY ALONEThe Lancet, 1987
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987
- Current Optimum Management of Anaplastic Germ Cell Tumours of the Testis and Other SitesBritish Journal of Urology, 1986
- Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumorsThe American Journal of Medicine, 1985
- VP16-213 as a single agent in advanced testicular tumorsPublished by Elsevier ,1980